Skip to main content

SB 226 — Hawaii

RELATING TO PRESCRIPTION DRUGS.

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

Official abstract, as published by the legislature.

  • SB 226 is a bill in the Hawaii Senate, 2026 session, introduced January 13, 2025.
  • Sponsored by ELEFANTE, CHANG, and DECOITE.
  • Current status: introduced.
  • Most recent action (December 8, 2025): Carried over to 2026 Regular Session.
  • Subjects: Clinical Practice Guidelines, Clinical Review Criteria, Exceptions, Health Insurance, Prescription Drugs, Step Therapy Protocol.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: ELEFANTE, CHANG, DECOITE

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Pending Introduction.
  2. Senate Introduced and passed First Reading. Milestone
  3. Senate Referred to HHS, CPN.
  4. Legislature Carried over to 2026 Regular Session. Latest

Source: Open States. Last checked November 16, 2026. How we keep this accurate ›